Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Diseases Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00040027
What this trial is testing

Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Who this might be right for
Hepatitis CHepatitis C, Chronic
SciClone Pharmaceuticals 500
Testing effectiveness (Phase 2)UnknownNCT05382351
What this trial is testing

Antiviral Therapy for Patients With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B Virus Infection
Sun Yat-sen University 238
Testing effectiveness (Phase 2)Study completedNCT06740149
What this trial is testing

Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients

Who this might be right for
Acute-On-Chronic Liver Failure
Sun Yat-sen University 90
Large-scale testing (Phase 3)Study completedNCT00371761
What this trial is testing

PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)

Who this might be right for
Hepatitis B, Chronic (CHB)
Merck Sharp & Dohme LLC 25
Post-approval studies (Phase 4)UnknownNCT02802280
What this trial is testing

Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents.

Who this might be right for
Hepatitis CCardiovascular Diseases
Instituto de Investigación Marqués de Valdecilla 80
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableUnknownNCT05357183
What this trial is testing

The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT01226446
What this trial is testing

Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 32
Not applicableStudy completedNCT00076427
What this trial is testing

Leukapheresis for Research on HCV-Coinfected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 327
Post-approval studies (Phase 4)Study completedNCT03241641
What this trial is testing

Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.

Who this might be right for
Chronic Hepatitis b
Young-Suk Lim 174
Testing effectiveness (Phase 2)Study completedNCT02794805
What this trial is testing

Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Meridian Bioscience, Inc. 74
Large-scale testing (Phase 3)Study completedNCT00262379
What this trial is testing

Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University Hospital, Angers 229
Post-approval studies (Phase 4)Study completedNCT05957380
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B
Dong-A ST Co., Ltd. 120
Not applicableEnded earlyNCT00723879
What this trial is testing

Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)

Who this might be right for
Hepatitis C, ChronicHepacivirus
Merck Sharp & Dohme LLC 115
Testing effectiveness (Phase 2)Study completedNCT01482403
What this trial is testing

Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 58
Not applicableLooking for participantsNCT05181826
What this trial is testing

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Who this might be right for
CancerLiver CirrhosisChronic Hepatitis+4 more
Helio Genomics 1,200
Large-scale testing (Phase 3)Study completedNCT01889433
What this trial is testing

An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C

Who this might be right for
HepatitisHepatitis C
Biocad 170
Not applicableLooking for participantsNCT06966908
What this trial is testing

Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 16,300
Early research (Phase 1)Study completedNCT00801255
What this trial is testing

Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Not applicableUnknownNCT01572233
What this trial is testing

Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
National Taiwan University Hospital 300
Next Page